calendar
3,776 catalysts · 3,728 phase readout · 2,108 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
next 91 dayslessmore
MonWedFri
3,776 catalysts · 3,728 phase readout · 2,108 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
Sponsor: Institut Curie. Phase: PHASE2. Conditions: Metastatic Breast Cancer ( HER2 Negative), Unresectable Breast Cancer
Sponsor: Columbia University. Phase: NA. Conditions: Educational Activities
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: AL Amyloidosis
Sponsor: Jiangsu BioJeTay Biotechnology Co., Ltd.. Phase: PHASE3. Conditions: Hemophilia
Sponsor: Hoffmann-La Roche. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Sponsor: Christian Candrian. Phase: NA. Conditions: Femoral Fracture
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Knee Osteoarthritis
Sponsor: Nordsjaellands Hospital. Phase: NA. Conditions: Primary Condition: Nerve Block, Secondary Condition: Catheter Displacement, Focus of Study: Sciatic Nerve
Sponsor: Duke University. Phase: NA. Conditions: Isolated Focal Hand Dystonia
Sponsor: Ain Shams University. Phase: PHASE3. Conditions: PreDiabetes
Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: . Conditions: Urolithiasis
Sponsor: Suven Life Sciences Limited. Phase: PHASE3. Conditions: Agitation, Alzheimer's Type Dementia
Sponsor: Thomas Jefferson University. Phase: . Conditions: Prostate Carcinoma
Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Brown Adipose Tissue (BAT) Physiology, Cold Exposure
Sponsor: Ibadat International University, Islamabad. Phase: NA. Conditions: Osteoarthritis (OA) of the Knee
Sponsor: Chinese University of Hong Kong. Phase: PHASE2. Conditions: HCC
Sponsor: Medical University of Bialystok. Phase: NA. Conditions: GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Sponsor: Vanderbilt University Medical Center. Phase: PHASE1. Conditions: Orthostatic Hypotension, Pure Autonomic Failure, Multiple System Atrophy, Autonomic Failure
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD. Phase: PHASE1. Conditions: Hepatic Impairment and Healthy Female
Sponsor: Ipsen. Phase: PHASE3. Conditions: Episodic Migraine
Sponsor: University of Health Sciences Lahore. Phase: NA. Conditions: Text Neck Syndrome
Sponsor: Fudan University. Phase: NA. Conditions: Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Metastatic Squamous Non-Small Cell Lung Cancer, Metastatic Nonsquamous Non-Small Cell Lung Cancer
Sponsor: Hoffmann-La Roche. Phase: PHASE4. Conditions: Multiple Sclerosis, Clinically Isolated Syndrome
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Connective Tissue Disorders, Osteogenesis Imperfecta, Bone Diseases, Metabolic, Melorheostosis
Sponsor: National Institute of Mental Health (NIMH). Phase: PHASE1. Conditions: Long COVID, Post Acute Sequelae of COVID-19
Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Spinal Cord Neoplasm
Sponsor: Samsun University. Phase: NA. Conditions: Acute Pain, Spinal Stenosis
Sponsor: Takeda. Phase: PHASE1. Conditions: Malignant Solid Tumors
Sponsor: Nigde Omer Halisdemir University. Phase: NA. Conditions: Dental Anxiety in Children, Pediatric Anxiety
Sponsor: University of Oviedo. Phase: . Conditions: Hypothyroidism Primary
Sponsor: Pfizer. Phase: . Conditions: Acute Lymphocytic Leukemia
Sponsor: LanZhou University. Phase: NA. Conditions: Colonoscopy, Bowel Preparation, Quality of Healthcare
Sponsor: Tri-Service General Hospital. Phase: NA. Conditions: Sleep Wake Disorders
Sponsor: Universidad Complutense de Madrid. Phase: NA. Conditions: Partial Edentulism, Tooth Loss / Rehabilitation
Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: NA. Conditions: Head and Neck Cancer
Sponsor: Bayer. Phase: PHASE2. Conditions: Metastatic Hormone-sensitive Prostate Cancer
Sponsor: Shanghai AbelZeta Ltd.. Phase: PHASE1. Conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer
Sponsor: BRADEN DULONG. Phase: NA. Conditions: Platelet Dysfunction, Cardiopulmonary Bypass
Sponsor: IVIEW Therapeutics Inc.. Phase: PHASE2. Conditions: Dry Eye
Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Alcohol Use Disorder, Alcohol Abuse, Alcohol Dependence, Craving
Sponsor: Incyte Corporation. Phase: PHASE2. Conditions: Cutaneous Squamous Cell Carcinoma
Sponsor: King Saud University. Phase: NA. Conditions: Obesity (Disorder), Morbid Obesity, Bariatric Sleeve Gastrectomy, Meal Time, Chronotype, Circadian Rhythm
Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Breast Cancer
Sponsor: University of Michigan Rogel Cancer Center. Phase: NA. Conditions: Cancer
Sponsor: Almirall, S.A.. Phase: PHASE2. Conditions: Alopecia Areata
Sponsor: Boston Scientific Corporation. Phase: . Conditions: Parkinson Disease, Essential Tremor, Dystonia
Sponsor: University of Warmia and Mazury in Olsztyn. Phase: NA. Conditions: Inguinal Hernia Repair, Postoperative Pain, TAP Block
Sponsor: National Jewish Health. Phase: . Conditions: Cystic Fibrosis
Sponsor: Dr. Mark Mulder. Phase: . Conditions: Cancer-related Pain, Pain Assessment, Artificial Intelligence (AI), Oncology, Oncology Pain, Database, Facial Expression, Voice, Cancer